Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00001137
Status:
COMPLETED
Last Update Posted:
2013-12-06
First Post:
2000-01-28
Brief Title:
Long-Term Data Collection From Participants in Adult AIDS Clinical Trials
Sponsor:
Advancing Clinical Therapeutics Globally for HIVAIDS and Other Infections
Organization:
Advancing Clinical Therapeutics Globally for HIVAIDS and Other Infections
Study Overview
Official Title:
Adult AIDS Clinical Trials Group Longitudinal Linked Randomized Trials ALLRT Protocol
Status:
COMPLETED
Status Verified Date:
2013-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine what combinations of anti-HIV drugs work best in patients treated over several years The study will also assess the occurrence of side effects and opportunistic infections in patients with low viral loads compared to those with higher viral loads
Detailed Description:
A compilation of outcomes of various antiretroviral therapies would be beneficial when evaluating which strategies are most effective in long-term treatment of HIV-1 Using data from present and recently completed studies this study will collect information on therapies and their control of HIV infection and maintenance of durable suppression of HIV-1 replication
No treatment is provided by this study but patients will continue to receive highly active antiretroviral therapy HAART from other studies in which they are coenrolled Blood and urine collection will occur at study entry and periodically throughout the study Women may undergo pelvic exams and Pap smears Portions of blood samples will be stored to evaluate genotypicphenotypic susceptibility testing Medical histories physical exams and questionnaires will be completed periodically
No treatment is provided by this study but patients will continue to receive highly active antiretroviral therapy HAART from other studies in which they are coenrolled Blood and urine collection will occur at study entry and periodically throughout the study Women may undergo pelvic exams and Pap smears Portions of blood samples will be stored to evaluate genotypicphenotypic susceptibility testing Medical histories physical exams and questionnaires will be completed periodically
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| AACTG A5001 | US NIH GrantContract | None | httpsreporternihgovquickSearch1U01AI068636 |
| 1U01AI068636 | NIH | None | None |